Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $6,975 | 1 | 73.4% |
| Travel and Lodging | $1,922 | 7 | 20.2% |
| Food and Beverage | $610.28 | 19 | 6.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sarepta Therapeutics, Inc. | $8,222 | 7 | $0 (2024) |
| Janssen Research & Development, LLC | $1,139 | 11 | $0 (2023) |
| HOSPIRA, INC. | $76.93 | 5 | $0 (2023) |
| Amgen Inc. | $41.11 | 2 | $0 (2018) |
| Apria Healthcare LLC | $16.13 | 1 | $0 (2021) |
| GENZYME CORPORATION | $12.91 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $8,222 | 7 | Sarepta Therapeutics, Inc. ($8,222) |
| 2023 | $1,202 | 15 | Janssen Research & Development, LLC ($1,139) |
| 2022 | $13.03 | 1 | HOSPIRA, INC. ($13.03) |
| 2021 | $16.13 | 1 | Apria Healthcare LLC ($16.13) |
| 2018 | $41.11 | 2 | Amgen Inc. ($41.11) |
| 2017 | $12.91 | 1 | GENZYME CORPORATION ($12.91) |
All Payment Transactions
27 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/23/2024 | Sarepta Therapeutics, Inc. | — | Consulting Fee | Cash or cash equivalent | $6,975.00 | General |
| 04/12/2024 | Sarepta Therapeutics, Inc. | — | Travel and Lodging | In-kind items and services | $410.66 | General |
| 04/12/2024 | Sarepta Therapeutics, Inc. | — | Travel and Lodging | In-kind items and services | $301.20 | General |
| 04/12/2024 | Sarepta Therapeutics, Inc. | — | Travel and Lodging | In-kind items and services | $265.07 | General |
| 04/12/2024 | Sarepta Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $90.45 | General |
| 04/12/2024 | Sarepta Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $50.00 | General |
| 04/11/2024 | Sarepta Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $129.75 | General |
| 12/06/2023 | Janssen Research & Development, LLC | — | Travel and Lodging | In-kind items and services | $226.11 | General |
| 12/06/2023 | Janssen Research & Development, LLC | — | Travel and Lodging | In-kind items and services | $86.00 | General |
| 12/06/2023 | Janssen Research & Development, LLC | — | Food and Beverage | In-kind items and services | $42.00 | General |
| 12/06/2023 | Janssen Research & Development, LLC | — | Food and Beverage | In-kind items and services | $26.00 | General |
| 12/06/2023 | Janssen Research & Development, LLC | — | Food and Beverage | In-kind items and services | $15.00 | General |
| 12/06/2023 | Janssen Research & Development, LLC | — | Food and Beverage | In-kind items and services | $15.00 | General |
| 12/05/2023 | Janssen Research & Development, LLC | — | Food and Beverage | In-kind items and services | $64.00 | General |
| 12/05/2023 | Janssen Research & Development, LLC | — | Travel and Lodging | In-kind items and services | $34.33 | General |
| 12/05/2023 | Janssen Research & Development, LLC | — | Food and Beverage | In-kind items and services | $19.80 | General |
| 12/05/2023 | Janssen Research & Development, LLC | — | Food and Beverage | In-kind items and services | $11.20 | General |
| 11/17/2023 | Janssen Research & Development, LLC | — | Travel and Lodging | In-kind items and services | $599.08 | General |
| 05/31/2023 | HOSPIRA, INC. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: IMMUNOLOGY | ||||||
| 03/17/2023 | HOSPIRA, INC. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA, CUTAQUIG | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: IMMUNOLOGY | ||||||
| 02/03/2023 | HOSPIRA, INC. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA, CUTAQUIG | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: IMMUNOLOGY | ||||||
| 01/24/2023 | HOSPIRA, INC. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA, CUTAQUIG | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: IMMUNOLOGY | ||||||
| 08/17/2022 | HOSPIRA, INC. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA, CUTAQUIG | Food and Beverage | In-kind items and services | $13.03 | General |
| Category: IMMUNOLOGY | ||||||
| 01/21/2021 | Apria Healthcare LLC | Medela (Device), Philips, Invacare | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: Wound care NPWT pump | ||||||
| 05/11/2018 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 342 | 367 | $92,216 | $27,174 |
| 2022 | 8 | 414 | 526 | $106,977 | $39,374 |
| 2021 | 9 | 448 | 588 | $120,827 | $46,723 |
| 2020 | 9 | 472 | 605 | $117,536 | $39,640 |
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 70 | 72 | $13,380 | $6,361 | 47.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 32 | 32 | $19,904 | $4,763 | 23.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 36 | 39 | $17,940 | $4,709 | 26.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 59 | 61 | $9,761 | $3,746 | 38.4% |
| 95910 | Nerve conduction, 7-8 studies | Facility | 2023 | 22 | 22 | $7,436 | $1,987 | 26.7% |
| 95911 | Nerve conduction, 9-10 studies | Facility | 2023 | 16 | 16 | $7,110 | $1,776 | 25.0% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2023 | 28 | 28 | $4,054 | $1,089 | 26.9% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 12 | 12 | $4,356 | $878.68 | 20.2% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Facility | 2023 | 38 | 52 | $3,072 | $808.68 | 26.3% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 11 | 11 | $3,311 | $778.80 | 23.5% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Office | 2023 | 18 | 22 | $1,892 | $276.80 | 14.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 128 | 189 | $32,402 | $18,452 | 56.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 89 | 113 | $17,897 | $7,723 | 43.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 41 | 41 | $12,990 | $4,918 | 37.9% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2022 | 34 | 34 | $12,155 | $2,801 | 23.0% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 27 | 27 | $16,156 | $2,593 | 16.1% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 28 | 31 | $4,555 | $1,094 | 24.0% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Office | 2022 | 55 | 78 | $8,612 | $1,092 | 12.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 12 | 13 | $2,210 | $701.05 | 31.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 142 | 225 | $37,748 | $23,101 | 61.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 82 | 103 | $16,388 | $6,868 | 41.9% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 43 | 43 | $13,248 | $5,885 | 44.4% |
| 95911 | Nerve transmission studies, 9-10 studies | Office | 2021 | 28 | 28 | $16,544 | $2,820 | 17.0% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 51 | 59 | $8,522 | $2,059 | 24.2% |
| 95910 | Nerve transmission studies, 7-8 studies | Office | 2021 | 23 | 23 | $8,056 | $1,881 | 23.4% |
About Dr. Duaa Jabari, MD
Dr. Duaa Jabari, MD is a Neuromuscular Medicine healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/24/2012. The National Provider Identifier (NPI) number assigned to this provider is 1124374442.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Duaa Jabari, MD has received a total of $9,508 in payments from pharmaceutical and medical device companies, with $8,222 received in 2024. These payments were reported across 27 transactions from 6 companies. The most common payment nature is "Consulting Fee" ($6,975).
As a Medicare-enrolled provider, Jabari has provided services to 1,676 Medicare beneficiaries, totaling 2,086 services with total Medicare billing of $152,910. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Practice Information
- Specialty Neuromuscular Medicine
- Other Specialties Neurology, Neurology
- Location Los Angeles, CA
- Active Since 07/24/2012
- Last Updated 08/29/2024
- Taxonomy Code 2084N0008X
- Entity Type Individual
- NPI Number 1124374442
Products in Payments
- OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug) $76.93
- Repatha (Biological) $41.11
- Medela (Device) $16.13
- AUBAGIO (Drug) $12.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neuromuscular Medicine Doctors in Los Angeles
Perry Shieh, Md, MD
Neuromuscular Medicine — Payments: $2.3M
Dr. Francy Shu, M.d, M.D
Neuromuscular Medicine — Payments: $154,478
Steven Cramer, Md, MD
Neuromuscular Medicine — Payments: $113,068
Payam Soltanzadeh, Md, MD
Neuromuscular Medicine — Payments: $7,068
Abel Wu, M.d, M.D
Neuromuscular Medicine — Payments: $575.55
Michael Chung
Neuromuscular Medicine — Payments: $563.58